Cargando…

Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept

INTRODUCTION: About 30% of rheumatoid arthritis patients fail to respond adequately to TNFα-blocking therapy. There is a medical and socioeconomic need to identify molecular markers for an early prediction of responders and nonresponders. METHODS: RNA was extracted from peripheral blood mononuclear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koczan, Dirk, Drynda, Susanne, Hecker, Michael, Drynda, Andreas, Guthke, Reinhard, Kekow, Joern, Thiesen, Hans-Juergen
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483439/ https://www.ncbi.nlm.nih.gov/pubmed/18454843 http://dx.doi.org/10.1186/ar2419

Ejemplares similares

Modulation of the gene expression pattern in peripheral blood mononuclear cells by biologicals in rheumatoid arthritis
por: Kekow, J, et al.
Publicado: (2003)

Putative IL-10 Low Producer Genotypes Are Associated with a Favourable Etanercept Response in Patients with Rheumatoid Arthritis
por: Schotte, Heiko, et al.
Publicado: (2015)

Long-term persistence and effects of fetal microchimerisms on disease onset and status in a cohort of women with rheumatoid arthritis and systemic lupus erythematosus
por: Kekow, Marianne, et al.
Publicado: (2013)

Complex genetic predisposition in adult and juvenile rheumatoid arthritis
por: Miterski, Bianca, et al.
Publicado: (2004)

Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still’s disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity
por: Kudela, Holger, et al.
Publicado: (2019)

Differential Effect of Cobalt and Chromium Ions as Well as CoCr Particles on the Expression of Osteogenic Markers and Osteoblast Function
por: Drynda, Andreas, et al.
Publicado: (2018)

Effects of TIMP-1 and TIMP-3 gene transfer on invasiveness, proliferation and apoptosis of rheumatoid arthritis (RA) synovial fibroblasts (RA-SF)
por: Pap, T, et al.
Publicado: (2002)

Batch correction of microarray data substantially improves the identification of genes differentially expressed in Rheumatoid Arthritis and Osteoarthritis
por: Kupfer, Peter, et al.
Publicado: (2012)

Molecular signatures of rheumatoid arthritis characterized by transcriptome and proteome analysis
por: Glocker, MO, et al.
Publicado: (2005)

Mechanisms of resistance against Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts
por: Pap, T, et al.
Publicado: (2003)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane
por: Huber, René, et al.
Publicado: (2008)

Novel application of multi-stimuli network inference to synovial fibroblasts of rheumatoid arthritis patients
por: Kupfer, Peter, et al.
Publicado: (2014)

Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation
por: Woetzel, Dirk, et al.
Publicado: (2014)

Pain experience in children with juvenile idiopathic arthritis on TNFalpha-inhibitors
por: Jeppesen, JH, et al.
Publicado: (2008)

Integrative modeling of transcriptional regulation in response to antirheumatic therapy
por: Hecker, Michael, et al.
Publicado: (2009)

Constitutive upregulation of the transforming growth factor-β pathway in rheumatoid arthritis synovial fibroblasts
por: Pohlers, Dirk, et al.
Publicado: (2007)

IGF and IGFBP as an index for discrimination between vitamin D supplementation responders and nonresponders in overweight Saudi subjects
por: Al-Daghri, Nasser M., et al.
Publicado: (2018)

Safety of etanercept in elderly subjects with rheumatoid arthritis
por: Lurati, Alfredomaria, et al.
Publicado: (2010)

Optimal dose of etanercept in the treatment of rheumatoid arthritis
por: Curtis, Elizabeth Mary, et al.
Publicado: (2014)

Identifying responders and nonresponders to interferon therapy in multiple sclerosis
por: Prosperini, Luca, et al.
Publicado: (2014)

Linking Federal Administrative Records to Respondents and Nonrespondents in Household Surveys: A Case Study
por: Sakshaug, Joseph, et al.
Publicado: (2017)

Increased susceptibility of osteoarthritis tenocytes to FasL-induced apoptosis is associated with elevated expression of Fas receptor but no alterations in the expression of Sentrin-1/SUMO-1
por: Machner, A, et al.
Publicado: (2003)

Methotrexate Treatment Suppresses Monocytes in Nonresponders to Pneumococcal Conjugate Vaccine in Rheumatoid Arthritis Patients
por: Elmér, Evelina, et al.
Publicado: (2022)

Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)
por: Gashi, Afrim A., et al.
Publicado: (2014)

Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
por: Chadwick, Laura, et al.
Publicado: (2018)

Long-term exposure of rheumatoid arthritis synovial fibroblasts to tumor necrosis factor alpha inhibits FasL-mediated apoptosis through activation of NF-κB and upregulation of the small ubiquitin-like modifier SUMO-1
por: Pap, T, et al.
Publicado: (2004)

Short‐term GAA loading: Responders versus nonresponders analysis
por: Ostojic, Sergej M.
Publicado: (2020)

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab
por: Marotte, Hubert, et al.
Publicado: (2007)

Adaptive differentiation of murine lymphocytes. IV. (Responder × Nonresponder) F(1) T cells can be taught to preferentially help nonresponder,rather than responder, B cells
por: Katz, DH, et al.
Publicado: (1979)

Higher susceptibility to Fas ligand induced apoptosis and altered modulation of cell death by tumor necrosis factor-α in periarticular tenocytes from patients with knee joint osteoarthritis
por: Machner, Andreas, et al.
Publicado: (2003)

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2011)

Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis
por: van Vollenhoven, Ronald F, et al.
Publicado: (2016)

A Pilot Dose‐Finding Study of Etanercept in Rheumatoid Arthritis
por: Breedveld, Ferdinand C., et al.
Publicado: (2017)

Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment
por: Cao, Jian, et al.
Publicado: (2019)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
por: BOSKOVIC, OLIVERA, et al.
Publicado: (2020)

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Focal cerebral ischemia in the TNFalpha-transgenic rat
por: Pettigrew, L Creed, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_srj2ps8h1j0eg12spno78g1rbi